WP9 - From target to therapy: A new combined structure for enhancement of early drug development

WP9 - From target to therapy: A new combined structure for enhancement of early drug development


CATS (Clinical Animal Trial Service)

One of the tasks for Combine is the enhancement of drug development, from target identification to early trials in experimental models, and to act as consultants for clinical trial planning when needed. We primarily seek to collaborate with small and medium sized companies and to make the unique competence within Combine available to our partners. Combine aims to be an asset for Swedish small sized companies in particular.

We offer preclinical evaluation of substance/drug in animal models for RA (Rheumatoid Arthritis) & MS (Multiple Sclerosis) in addition to a number of in vitro testing sytems.